Browsing: Wellness Tips

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>

The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court in New Jersey against Eli Lilly and Company (NYSE:LLY) on July 21, accusing its primary rival of false advertising and unfair competition regarding television and digital campaigns…

MedPal AI (MPAL ), the AI-native digital health and pharmacy group, has highlighted that the UK has become the first country in Europe to authorise orforglipron (brand name Foundayo), Eli Lilly’s once daily oral GLP-1 tablet

MedPal AI plc (AIM: MPAL)has highlighted the UK approval of Eli Lilly’s once-daily oral GLP-1 treatment, Foundayo, which has been authorised for weight loss and weight maintenance in eligible adults

Medicare’s New GLP-1 Bridge: Weight-Loss Help for $50 a Month – Daily Independent Skip to main content Log in SPONSORED CONTENT

As GLP-1 frenzy grips India, firms race to build businesses around the weight-loss drug boom Trending Topics

Prior obesity neuroimaging studies used univariate methods and small samples, limiting reproducibility. Employing a large-scale dataset and a two-stage machine learning framework, we identified neuroanatomical signatures of obesity and evaluated their population-level associations with delay discounting impulsivity

When Heather Bade started taking weight loss medication, she hoped it would be the answer. Instead, the side effects nearly brought her to a standstill

Social media has labelled GLP-1 receptor agonists as “miracle” weight-loss drugs. However, these medicines represent more than a passing trend. Obesity is a complex chronic disease often associated with diabetes, hypertension and cardiovascular problems. GLP-1 receptor agonists, initially developed for type 2 diabetes, now play an important role in obesity management

News Sports News Cricket News Sarfaraz Khan’s return: A 17kg weight loss, relentless fight and a Test recall Trending India Vs Sri Lanka Ashmita Chaliha Neel Patel Hezly Rivera Sarfaraz Khan’s return: A 17kg weight loss, relentless fight and a Test recall Gaurav Gupta / TNN / Updated: Aug 11, 2026, 08:46 IST Comments AAText…